Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Parkinsonism is a complex neurodegenerative disorder with genetic underpinnings.
• Early-onset parkinsonism (<50 years) often presents diagnostic challenges.
• The PTEN-induced kinase 1 (PINK1) gene is implicated in familial Parkinson's disease.

Purpose of the Study:

• To determine the frequency and characteristics of PINK1 gene mutations in early-onset parkinsonism.
• To investigate the phenotypic spectrum associated with PINK1 mutations.
• To assess the genetic contribution of PINK1 to sporadic and familial forms of early-onset parkinsonism.

Main Methods:

• Genetic sequencing of the entire PINK1 coding region in 134 early-onset parkinsonism patients and 90 controls.
• Analysis of genomic DNA and cDNA to identify mutations.
• Clinical phenotyping of patients with identified mutations.

Main Results:

• Homozygous pathogenic PINK1 mutations were found in 4.4% of sporadic Italian patients.
• Novel mutations (Gln456Stop, Pro196Leu) were identified.
• Patients with homozygous mutations exhibited very early onset, slow progression, and significant l-dopa responsiveness, resembling parkin-related disease.

Conclusions:

• PINK1 homozygous mutations are a relevant cause of sporadic early-onset parkinsonism in the Italian population.
• The clinical phenotype associated with homozygous PINK1 mutations includes early onset and good l-dopa response.
• The role of single heterozygous PINK1 mutations requires further investigation, potentially involving interaction with other genetic factors.